Abstract
To examine components ofGanoderma lucidum for anti-human immunodeficiency virus (HIV) activity, the aqueous extracts of its basidiocarps were separated into high-molecular-weight (HMF) and low-molecular-weight (LMF) fractions. These fractions were used in XTT [2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide] antiviral assay which can quantitatively measure cytopathic effects of HIV-1 on CEM, human T lymphoblastoid cell line. The CEM cell line added with serial diluted HMF or LMF was cultured in the absence or presence of HIV-1. The results showed that the LMF of the aqueous extract strongly inhibited cytopathic effect of the target cell induced by HIV-1. When two-fold serially diluted LMF ranging from 0.97 μg/ml to 125.00 μg/ml was added to the virus-free culture system, no toxicity on the target cells was detected in all the concentrations tested. However, when it was added to the HIV-infected culture system, the viabilities of the target cell reached a plateau recovering its viabilities to 71.7% and 82.5% in experiment-1 and-2 at 15.60 μg/ml, respectively. The cell viabilities were then gradually decreased but maintained at more than 50% above 31.20 μg/ml concentration. On the contrary, HMF did not prevent any HIV-induced cytopathic effect at any concentrations tested on this cell line. From these results, negligible toxicities were observed by both HMF and LMF ofG. lucidum, and recovery of cell viability in HIV infected target cell was induced only by LMF of the carpophores.
Similar content being viewed by others
References Cited
Dornsife, R. E. and Averett, D. R.,In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans.Antimicrob. Agents Chemother., 40, 514–519 (1996).
Hatanaka, K., Yoshida, T., Uryu, T., Yoshida, O., Nakashima, H., Yamamoto, N., Mimura, T. and Kaneko, Y., Synthesis of an inhibitor of human immunodeficiency virus infection.Jpn. J. Cancer Res., 80, 95–98 (1989).
Hikino, H., Konno, C., Mirin, Y. and Hayashi, T., Isolation and hypoglycemic activity of ganoderans A and B, glycans ofGanoderma lucidum fruit bodies.Planta Med., 339–340 (1985).
Hirotani, M., Furuya, T. and Shiro, M., A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid fromGanoderma lucidum.Phytochem., 24, 2055–2061 (1985).
Jong, S. C. and Birmingham, J. M., Medicinal benefits of the mushroomGanoderma.Adv. Appl. Microbiol., 37, 101–134 (1992).
Kim, B. K., Chung, H. S., Chung, K. S. and Yang, M. S., Studies on the antineoplastic components of Korean basidiomycetes.Kor. J. Mycol., 8, 107–113 (1980).
Kim, M. J., Kim, H. W., Lee, Y. S., Shim, M. J., Choi, E. C. and Kim, B. K., Studies on safety ofGanoderma lucidum.Kor. J. Mycol., 14, 49–59 (1986).
Kim, S. H., Kim, H. W., Choi, E. C. and Kim, B. K., Immunological studies on Collyban ofCollybia confluens.J. Kor. Cancer Assoc., 25, 288–298 (1993).
Kimura, Y., Tsuda, K., Arichi, S. and Takahashi, N., Effects ofGanoderma lucidum on carbohydrate metabolism.Basic Sci. Clin. Med., 17, 2127–2130 (1983).
Kino, K., Mizumoto, K., Sone, T., Yamaji, T., Watanabe, J., Yamaoka, K., Shimizu, K., Ko, K. and Tsunoo, H., An immunomodulatory protein, Ling Zhi-8 prevents insulitis in non-obese diabetic mice.Diabetologia, 33, 713–718 (1990).
Kino, K., Sone, T., Watanebe, J., Yamashita, A., Tsuboi, H., Miyajima, H. and Tsunoo, H., Immunomodulator, Ling Zhi-8 prevents antibody production in mice.Int. J. Immunopharmacol., 13, 1109–1115 (1991).
Kino, K., Yamashita, A., Yamaoka, K., Watanabe, J., Tanaka, S., Ko, K., Shimizu, K. and Tsunoo, H., Isolation and characterization of a new immunomodulatory protein, Ling Zhi-8 fromGanoderma lucidum.J. Biol. Chem., 264, 472–478 (1989).
Kitade, Y., Suzuki, A., Hirota, K., Maki, Y., Nakane, H., Ono, K., Baba, M. and Shigeta, S., Synthesis and anti-human immunodeficiency virus type-1 (HIV-1) activity of 3-substituted derivatives of 3′-azido-3′-deoxythymidine (AZT), and inhibition of HIV-1 reverse transcriptase by their 5′-triphosphates.Chem. Pharm. Bull., 40, 920–924 (1992).
Kohda, H., Tokumoto, W., Sakamoto, K., Fujii, M., Hirai, Y., Yamasaki, K., Komoda, Y., Nakamura, H., Ishihara, S. and Uchida, M., The biologically active constituents ofGanoderma lucidum.Chem. Pharm. Bull., 33, 1367–1374 (1985).
Komoda, Y., Nakamura, H., Ishihara, S., Uchida, M., Kohda, H. and Yamasaki, K., Structures of new terpenoid constituents ofGanoderma lucidum.Chem. Pharm. Bull., 33, 4829–4835 (1985).
Konoshima, T., Yasuda, I., Kashiwada, Y., Cosentino, L. M. and Lee, K. H., Anti-AIDS agents, 21. Triterpenoid saponins as anti-HIV principles from fruit ofGleditsia japonica andGymnocladus chinensis, and a structure-activity correlation.J. Nat. Prod., 58, 1372–1377 (1995).
Kubo, M., Matsuda, K., Tanaka, K., Arichi, S. and Tsuda, K., Studies onGanoderma lucidum (III). Effects on experimental hyperlipoic blood.Basic Sci. Clin. Med., 14, 2455–2460 (1980).
Kubota, T., Asaka, Y., Miura, I. and Mori, H., Structure of ganoderic acid A and B, two new lanostane type bitter triterpenes fromGanoderma lucidum.Helv. Chim. Acta, 65, 611–619 (1982).
Larder, B. A., Darby, G. and Richman, D. D., HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.Science, 243, 1731–1734 (1989).
Levin, T. L., Berdon, W. E., Tan, H. B. and Haller, J. O., Dideoxyinosine-induced pancreatitis in human immunodeficiency virus-infected children.Pediatr. Radiol., 27, 189–191 (1997).
Miyamoto, T. and Abe, H., Hair growth cosmetics.Jpn. Pat., 60-94907 (1985).
Miyazaki, T. and Nishijima, M., Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide ofGanoderma lucidum.Chem. Pharm. Bull., 29, 3611–3616 (1981).
Mizuno, T.,Ganoderma lucidum antihypertensive component.Chem. Biol. (Jpn), 21, 473–479 (1983).
Mizuno, T., Kim, B. K. and Il-Yang Pharm. Co. in Mizuno, T., and Kim, B. K. (Eds.)Ganoderma lucidum, Il-Yang Pharm. Co., Ltd., Seoul, pp. 99–103 1996.
Morinaga Milk Ind. Co., Ltd.Jpn. Kokai Tokkyo Koho, 81-57801 (1981).
Murasugi, A., Tanaka, S., Komiyama, N., Iwata, N., Kino, K., Tsunoo, H. and Sakuma, S., Molecular cloning of a cDNA and a gene encoding an immunomodulatory protein, Ling Zhi-8 from a fungus,Ganoderma lucidum.J. Biol. Chem., 266, 2486–2493 (1991).
Nara, P. L., Hatch, W. C., Dunlop, N. M., Robey, W. G., Arrhur, L. O., Gonda, M. A. and Fischinger, P. J., Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.AIDS Res. Hum. Retrov., 3, 283–302 (1987).
Nishitoba, T., Sato, H. and Sakamura, S., New terpenoids fromGanoderma lucidum and their bitterness.Agric. Biol. Chem., 49, 1547–1549 (1985).
Park, J. H., Kim, H. W., Kim, Y. C., Choi, E. C. and Kim, B. K., Studies on antihypertensive components ofGanoderma lucidum in Korea.Kor. J. Food Hygiene, 2, 57–65 (1987).
Schmued, L. C., Albertson, C. M., Andrews, A., Sandberg, J. A., Nickols, J. and Slikker, W. Jr., Evaluation of brain and nerve pathology in rats chronically dosed with ddl or isoniazid.Neurotoxicol. Teratol., 18, 555–563 (1996).
Shimizu, A., Yano, T., Saito, Y. and Inada, Y., Isolation of an inhibitor of platelet aggregation from a fungus,Ganoderma lucidum.Chem. Pharm. Bull., 33, 3012–3015 (1985).
Sone, Y., Okuda, R., Wada, N., Kishida, E. and Misaki, A., Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium ofGanoderma lucidum.Agric. Biol. Chem., 49, 2641–2653 (1985).
Sugiura, M. and Ito, H., Toxicological studies ofGanoderma lucidum.Tokyo Yakka Daigaku Kenkyu Nenpo, 27, 722–733 (1977).
Suzuki, H., Iiyama, K., Yoshida, O., Yamazaki, S., Yamamoto, N. and Toda, S., Structural characterization of the immunoactive and antiviral water-soluble lignin in an extract of the culture medium ofLentinus edodes mycelium (LEM).Agric. Biol. Chem., 54, 479–487 (1990).
Suzuki, H., Okubo, A., Yamazaki, S., Suzuki, K., Mitsuya, H. and Toda, S., Inhibition of the infectivity and cytopathic effect of human immunodeficiency virus by water-soluble lignin in an extract of the culture medium ofLentinus edodes mycelium (LEM).Biochem. Biophys. Res. Comm., 160, 367–373 (1989).
Takehara, M., Luida, K. and Mori, K., Antiviral activity of virus-like particles fromLentinus edodes (Shiitake).Arch. Virol., 59, 269–274 (1979).
Tan, G. T., Pezzuto, J. M., Kinghorn, A. D. and Hughes, S. H., Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.J. Nat. Prod., 54, 143–154 (1991).
Tanaka, S., Ko, K., Kino, K., Tsuchiya, K., Yamashita, A., Murasugi, A., Sakuma, S. and Tsunoo, H., Complete amino acid sequence of an immunomodulatory protein, Ling Zhi-8 fromGanoderma lucidum having similarity to immunoglobulin variable regions.J. Biol. Chem., 264, 16372–16377 (1989).
Toth, J. O., Luu, B. and Ourisson, G., Ganoderic acid T and Z: cytotoxic triterpenes fromGanoderma lucidum.Tetrahedron Lett., 24, 1081–1084.
Weislow, O. S., Kiser, R., Fine, D. L., Bader, J., Shoemaker, R. H. and Boyd, M. R., New soluble formazan assay for HIV-1 cytopathic effects: application to high flux screening of synthetic and natural products for AIDS-antiviral activity.J. Natl. Cancer Inst., 81, 577–586 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, H.W., Shim, M.J., Choi, E.C. et al. Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract ofGanoderma lucidum . Arch. Pharm. Res. 20, 425–431 (1997). https://doi.org/10.1007/BF02973934
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02973934